Royalty Payment Schedule. The royalty fees are due and payable according to the following schedule or on such other schedule specified in the Manual:
Royalty Payment Schedule. The Licensee will pay to Institute all Earned Royalties payable to Institute quarterly on or before February 28 (for the Calendar Quarter ending December 31), May 31 (for the Calendar Quarter ending March 31), August 31 (for the Calendar Quarter ending June 30) and November 30 (for the Calendar Quarter ending September 30) of each calendar year. Each payment will be for Earned Royalties accrued within the Licensee’s most recently completed Calendar Quarter.
Royalty Payment Schedule. Within five (5) business days after the end of each Fiscal Quarter during which a Royalty-Bearing Product in the Field of Use is sold by Allergan, its Affiliates or its or their Sublicensees in the Royalty Territory, Allergan shall provide to Spectrum the estimated royalty payment calculation for Spectrum to complete its quarterly accounting close. Within forty-five (45) days after the end of each Fiscal Quarter during which a Royalty-Bearing Product in the Field of Use is sold by Allergan, its Affiliates or its or their Sublicensees in the Royalty Territory, Allergan shall deliver to Spectrum a detailed report, which shall include at least: (a) the net quantity sold, total sales, total to net deducts, and Royalty-Bearing Net Sales of Royalty-Bearing Product in the Field of Use for which royalties are due hereunder that it has sold in the prior Fiscal Quarter; (b) the calculation in U.S. dollars of royalty payments due hereunder with respect to such sales; and (c) the total due hereunder for such Fiscal Quarter, including deduction for any offsets. Simultaneously with the delivery of each such report, Allergan shall pay to Spectrum the amount specified in Section 6.5(c). Notwithstanding the foregoing, to the extent that Royalty-Bearing Net Sales also include Sublicensee Net Sales of Royalty-Bearing Product (including under Sections 6.3 and 6.4), Allergan shall have additional time as reasonably necessary to provide Spectrum with the information relating to such Sublicensee Net Sales of Royalty-Bearing Product in the foregoing report and payment or to determine whether the sales milestones have been met and subsequently make payments therefor.
Royalty Payment Schedule. Within forty-five (45) days after the end of each calendar quarter (ending on the last day of each March, June, September and December) during which a Licensed Product is sold by AntriaBio, its Affiliates or sublicensees or during which Sublicense Revenue is received by AntriaBio or its Affiliates, AntriaBio shall deliver to ActiveSite a detailed report, which shall include at least:
Royalty Payment Schedule. Freeze Tag will pay DEVELOPER its earned Royalties on a quarterly basis via check through the US mail (or other certified delivery service) no later than thirty (30) days after the close of the quarter in which royalties have been received by Freeze Tag. Freeze Tag’s fiscal year end is December 31. At DEVELOPER’s request, Freeze Tag will make the Royalty Payment via wire transfer, but the wire transfer fee for this transaction will be subtracted as an expense from the Royalties due to DEVELOPER.
Royalty Payment Schedule. Guaranteed Minimum Royalties shall be due and payable by Licensee to Licensor in installments as shown above. All other Royalties set forth above, including percentage royalties in excess of minimum royalties, shall be due and payable by Licensee to Licensor in quarterly installments on the twentieth (20th) day after the close of each contract quarter (on a pro rata basis for any period less than twelve (12) months).
Royalty Payment Schedule. Royalty payments shall be paid within 45 days after the completion of each calendar quarter.
Royalty Payment Schedule. Within five (5) business days after the end of each Fiscal Quarter during which a Royalty Product is sold by Spectrum, its Affiliates or its or their sublicensees, Spectrum shall provide to Allergan the estimated royalty payment calculation. Within forty-five (45) days after the end of each Fiscal Quarter during which a Royalty Product is sold by Allergan, its Affiliates or its or their sublicensees, Spectrum shall deliver to Allergan a detailed report, which shall include at least: (i) the net quantity sold, total sales, total to net deductions, and Net Sales of Royalty Product sold in the prior Fiscal Quarter; (ii) the calculation in U.S. dollars of royalty payments due hereunder with respect to such sales; and (iii) the total due hereunder for such Fiscal Quarter. Simultaneously with the delivery of each such report, Spectrum shall pay to Allergan the total due hereunder for such Fiscal Quarter.
Royalty Payment Schedule. Payments under Section 4.1 shall be payable to IntelliPharmaCeutics on a quarterly basis, within thirty (30) days after the end of each calendar quarter; provided, however, at the end of a calendar year, Larasan shall determine the actual amounts owed to IntelliPharmaCeutics under Section 4.1 and any additional amounts owed to IntelliPharmaCeutics for the first three calendar quarters of such calendar year shall be paid with the payment for the last calendar quarter of such calendar year, and provided further in the event that Larasan's payments for such calendar quarters exceed the actual amounts owed for such calendar quarters, Larasan shall have the right to offset such excess payments against the payment for the last calendar quarter of such calendar year. Only one payment will be due on Net Sales of the Licensed Product, even though the manufacture, sale or use of such Licensed Product may be covered by more than one intellectual property right in a country.
Royalty Payment Schedule. All amounts due WBG under Paragraph 2.2 shall be paid by TTC on a monthly basis within thirty (30) days of the end of each such month, to be adjusted on a quarterly basis from reports prepared for quarterly accounting. TTC shall include with each payment a report of the applicable Gross Revenues so the amount payable to WBG hereunder can be accurately determined.
